remacemide has been researched along with Aura in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (44.44) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anger, T; Madge, DJ; Mulla, M; Riddall, D | 1 |
| Dean, AD; Edgar, C; Wesnes, KA; Wroe, SJ | 1 |
| Alderfer, V; Devinsky, O; Faught, E; Holdich, TA; Leppik, IE; Pellock, JM; Schachter, S; Vazquez, B | 1 |
| Boehrer, A; Nehlig, A | 1 |
| Borowicz, KK; Czuczwar, SJ; Luszczki, JJ; Malek, R; Patsalos, PN; Ratnaraj, N | 1 |
| Patsalos, PN; Sander, JW | 1 |
| Blacklaw, J; Brodie, MJ; Jamieson, V; Jones, T; Leach, JP; Richens, A | 1 |
| Meldrum, BS | 1 |
| Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E | 1 |
| Davies, JA | 1 |
| Brodie, MJ; Girvan, J; Jamieson, V; Jones, T; Leach, JP; Richens, A | 1 |
| Jamieson, V; Lucas, SB; Mawer, GE; Wild, JM | 1 |
| Schachter, SC; Tarsy, D | 1 |
| Besag, FM; Blakey, GE; Dean, AD; Newton, RE | 1 |
| Brodie, MJ; Santangeli, S; Sills, GJ; Stone, TW | 1 |
| Blume, WT; Guberman, A; Holdich, TA; Jones, MW; Lee, MA; Pillay, N; Veloso, F; Weaver, DF | 1 |
| Betts, TA; Boddie, HG; Chadwick, DW; Crawford, PM; Holdich, TA; Lindstrom, P; Newman, PK; Soryal, I; Wroe, S | 1 |
| Muir, KT; Palmer, GC | 1 |
6 review(s) available for remacemide and Aura
| Article | Year |
|---|---|
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke | 2001 |
Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Topics: Acetamides; Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dioxolanes; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lamotrigine; Levetiracetam; Nipecotic Acids; Oxcarbazepine; Phenobarbital; Phenylcarbamates; Piracetam; Propylene Glycols; Risk Factors; Tiagabine; Topiramate; Triazines; Vigabatrin; Zonisamide | 1994 |
Update on the mechanism of action of antiepileptic drugs.
Topics: 4-Aminobutyrate Transaminase; Acetamides; Acetates; Amines; Animals; Anticonvulsants; Cyclohexanecarboxylic Acids; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Ion Channels; Lamotrigine; Membrane Potentials; Mice; Neurotransmitter Agents; Nipecotic Acids; Phenethylamines; Phenylcarbamates; Propylene Glycols; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Tiagabine; Topiramate; Triazines; Vigabatrin | 1996 |
Remacemide hydrochloride: a novel antiepileptic agent.
Topics: Acetamides; Animals; Anticonvulsants; Biotransformation; Epilepsy; Excitatory Amino Acid Antagonists; Humans; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Seizures | 1997 |
Remacemide: current status and clinical applications.
Topics: Acetamides; Animals; Anticonvulsants; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Humans; Huntington Disease; Intraoperative Complications; Neuroprotective Agents; Parkinson Disease; Phenethylamines; Receptors, N-Methyl-D-Aspartate | 2000 |
Remacemide.
Topics: Acetamides; Animals; Anticonvulsants; Brain; Drugs, Investigational; Electroencephalography; Epilepsy; Evoked Potentials; Humans; Mice; Rats | 1991 |
7 trial(s) available for remacemide and Aura
| Article | Year |
|---|---|
The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Attention; Carbamazepine; Child; Cognition; Double-Blind Method; Epilepsy; Female; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Recognition, Psychology; Reference Values; Reproducibility of Results; Treatment Outcome; Young Adult | 2009 |
A double-blind, placebo-controlled study of remacemide hydrochloride in patients with refractory epilepsy following pre-surgical assessment.
Topics: Acetamides; Adult; Anticonvulsants; Combined Modality Therapy; Double-Blind Method; Epilepsy; Female; Humans; Male; Middle Aged; Neurosurgical Procedures | 2002 |
Mutual interaction between remacemide hydrochloride and carbamazepine: two drugs with active metabolites.
Topics: Acetamides; Adult; Anticonvulsants; Carbamazepine; Cross-Over Studies; Double-Blind Method; Drug Interactions; Epilepsy; Female; Humans; Male; Middle Aged; Placebos | 1996 |
Lack of pharmacokinetic interaction between remacemide hydrochloride and sodium valproate in epileptic patients.
Topics: Acetamides; Adult; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Drug Interactions; Epilepsy; Female; Humans; Male; Middle Aged; Valproic Acid | 1997 |
Adjustment of carbamazepine dose to offset the effects of the interaction with remacemide hydrochloride in a double-blind, multicentre, add-on drug trial (CR2237) in refractory epilepsy.
Topics: Acetamides; Anticonvulsants; Carbamazepine; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Placebos; Research Design; Treatment Outcome | 1999 |
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg/day) in a B.I.D. regimen.
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Phenytoin | 2002 |
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen.
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Phenytoin; Statistics, Nonparametric | 2002 |
5 other study(ies) available for remacemide and Aura
| Article | Year |
|---|---|
Effects of remacemide in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.
Topics: Acetamides; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy; Male; Rats; Rats, Mutant Strains; Rats, Wistar; Seizures | 2003 |
Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
Topics: Acetamides; Algorithms; Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Electroshock; Epilepsy; Epilepsy, Tonic-Clonic; Male; Memory; Mice; Motor Skills; Phenobarbital; Phenytoin; Seizures; Valproic Acid | 2007 |
Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference.
Topics: Acetamides; Animals; Anticonvulsants; Azetidines; Carbamates; Drug Evaluation, Preclinical; Drugs, Investigational; Epilepsy; Humans; Israel; Levetiracetam; Nipecotic Acids; Phenylenediamines; Piracetam; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Thiazoles; Tiagabine; Triazoles | 1996 |
Safety, tolerability, and pharmacokinetics of remacemide in children.
Topics: Acetamides; Adolescent; Adult; Anticonvulsants; Biotransformation; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Induction; Epilepsy; Female; Humans; Male; Pilot Projects | 2001 |
Differential effects of remacemide and desglycinyl-remacemide on epileptiform burst firing in the rat hippocampal slice.
Topics: 4-Aminopyridine; Acetamides; Action Potentials; Animals; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Excitatory Amino Acid Antagonists; Hippocampus; Magnesium Deficiency; Male; Neurons; Phenethylamines; Pyridines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Sodium Channel Blockers; Sodium Channels | 2002 |